Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fezolinetant in Japanese women with menopausal hot flashes
NCT06206408Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fezolinetant in vasomotor symptoms, sponsored by Astellas Pharma. Started Feb 2024; status: completed.
02
Drugs
fezolinetant
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT06206408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06206408.